BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36111899)

  • 1. Retraction Note: Salinomycin enhances radiotherapy sensitivity and reduces expressions of BIRC5 and NEIL2 in nasopharyngeal carcinoma.
    Chang Y; Geng Q; Bao Q; Hu P
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6012. PubMed ID: 36111899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retraction Note: METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.
    Meng QZ; Cong CH; Li XJ; Zhu F; Zhao X; Chen FW
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):4947. PubMed ID: 35916787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction Note: Effect of atorvastatin on pulmonary arterial hypertension in rats through PI3K/AKT signaling pathway.
    Wang YY; Cheng XD; Jiang H
    Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):7881. PubMed ID: 37750615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction Note: MicroRNA-199a regulates myocardial fibrosis in rats by targeting SFRP5.
    Chen MH; Liu JC; Liu Y; Hu YC; Cai XF; Yin DC
    Eur Rev Med Pharmacol Sci; 2024 Apr; 28(7):2631. PubMed ID: 38639499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retraction Note: MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1.
    Chen JY; Xu LF; Hu HL; Wen YQ; Chen D; Liu WH
    Eur Rev Med Pharmacol Sci; 2024 May; 28(10):3476. PubMed ID: 38856147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction Note: Role of long non-coding RNA SNHG1 in occurrence and progression of ovarian carcinoma.
    Ge J; Wu XM; Yang XT; Gao JM; Wang F; Ye KF
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6013. PubMed ID: 36111900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction Note: MicroRNA-375 accelerates the invasion and migration of colorectal cancer through targeting RECK.
    Wei LJ; Bai DM; Wang ZY; Liu BC
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1229. PubMed ID: 36876660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retraction Note.
    Listed NA
    Eur Rev Med Pharmacol Sci; 2024 Apr; 28(8):3287. PubMed ID: 38708487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retraction Note: LncRNA RUSC1-AS1 promotes the proliferation of breast cancer cells by epigenetic silence of KLF2 and CDKN1A.
    Hu CC; Liang YW; Hu JL; Liu LF; Liang JW; Wang R
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6404. PubMed ID: 36196690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retraction Note: Knockdown of long non-coding RNA LUCAT1 reverses high glucose-induced cardiomyocyte injury via targeting CYP11B2.
    Yin Y; Yang ZF; Li XH; Zhou LQ; Zhang YJ; Yang B
    Eur Rev Med Pharmacol Sci; 2022 Nov; 26(21):7732. PubMed ID: 36394719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction Note: The carcinogenic complex lncRNA FOXP4-AS1/EZH2/LSD1 accelerates proliferation, migration and invasion of gastric cancer.
    Chen RY; Ju Q; Feng LM; Yuan Q; Zhang L
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(15):5311. PubMed ID: 35993622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retraction Note: MiR-195-5p inhibits the cell migration and invasion of cervical carcinoma through suppressing ARL2.
    Pan SS; Zhou HE; Yu HY; Xu LH
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9477. PubMed ID: 37916316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retraction Note: LncRNA BRE-AS1 acts as a tumor suppressor factor in bladder cancer via mediating STAT3.
    Zhang L; Liu B; Deng QH; Li JX
    Eur Rev Med Pharmacol Sci; 2023 May; 27(10):4326. PubMed ID: 37259712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retraction Note: MiR-1294 acts as a tumor suppressor in clear cell renal cell carcinoma through targeting HOXA6.
    Pan W; Pang LJ; Cai HL; Wu Y; Zhang W; Fang JC
    Eur Rev Med Pharmacol Sci; 2024 Jun; 28(11):3700. PubMed ID: 38884519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retraction Note: Long non-coding RNA DLEU7-AS1 promotes the occurrence and development of colorectal cancer via Wnt/β-catenin pathway.
    Liu XB; Han C; Sun CZ
    Eur Rev Med Pharmacol Sci; 2024 Apr; 28(7):2630. PubMed ID: 38639498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retraction Note: Lixisenatide protects doxorubicin-induced renal fibrosis by activating wNF-κB/TNF-α and TGF-β/Smad pathways.
    Guo NF; Cao YJ; Chen X; Zhang Y; Fan YP; Liu J; Chen XL
    Eur Rev Med Pharmacol Sci; 2023 Jul; 27(14):6472. PubMed ID: 37522656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction Note: MicroRNA-132 stimulates the growth and invasiveness of trophoblasts by targeting DAPK-1.
    Wang YP; Zhao P; Liu JY; Liu SM; Wang YX
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4545. PubMed ID: 35856341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retraction Note: Correlation between COVID-19 and air pollution: the effects of PM2.5 and PM10 on COVID-19 outcomes.
    Kalluçi E; Noka E; Bani K; Dhamo X; Alimehmeti I; Dhuli K; Madeo G; Micheletti C; Bonetti G; Zuccato C; Borghetti E; Marceddu G; Bertelli M
    Eur Rev Med Pharmacol Sci; 2024 Jun; 28(11):3699. PubMed ID: 38884518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retraction Note: Circular RNA circ_0079593 promotes glioma development through regulating KPNA2 expression by sponging miR-499a-5p.
    Yang Z; Li C; Fan XY; Liu LJ
    Eur Rev Med Pharmacol Sci; 2022 Oct; 26(20):7317. PubMed ID: 36314300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retraction Note: Combination therapy with metformin and IL-12 to inhibit the growth of hepatic carcinoma by promoting apoptosis and autophagy in HepG2-bearing mice.
    Jin Z; Jia BX; Tan LD; Chen QM; Liu YH
    Eur Rev Med Pharmacol Sci; 2022 Oct; 26(19):6892. PubMed ID: 36263565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.